Cargando…
Network Pharmacology and Molecular Docking-Based Investigation of Potential Targets of Astragalus membranaceus and Angelica sinensis Compound Acting on Spinal Cord Injury
BACKGROUND: Astragalus membranaceus (Huang-qi, AM) and Angelica sinensis (Dang-gui, AS) are common Chinese herbal medicines and have historically been used in spinal cord injury (SCI) therapies. However, the underlying molecular mechanisms of AM&AS remain little understood. The purpose of this r...
Autores principales: | Cao, Shengnan, Hou, Guangjian, Meng, Ya, Chen, Yuanzhen, Xie, Liangyu, Shi, Bin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9499798/ https://www.ncbi.nlm.nih.gov/pubmed/36157206 http://dx.doi.org/10.1155/2022/2141882 |
Ejemplares similares
-
Retracted: Network Pharmacology and Molecular Docking-Based Investigation of Potential Targets of Astragalus membranaceus and Angelica sinensis Compound Acting on Spinal Cord Injury
por: Markers, Disease
Publicado: (2023) -
Effect of Dangguibohyul-Tang, a Mixed Extract of Astragalus membranaceus and Angelica sinensis, on Allergic and Inflammatory Skin Reaction Compared with Single Extracts of Astragalus membranaceus or Angelica sinensis
por: Choi, You Yeon, et al.
Publicado: (2016) -
Insights
into the
Mechanism of Supramolecular Self-Assembly
in the Astragalus membranaceus–Angelica sinensis Codecoction
por: Liang, Pan, et al.
Publicado: (2023) -
Prediction and validation of potential molecular targets for the combination of Astragalus membranaceus and Angelica sinensis in the treatment of atherosclerosis based on network pharmacology
por: Wang, Tianyue, et al.
Publicado: (2022) -
The Combination of Astragalus membranaceus and Angelica sinensis Inhibits Lung Cancer and Cachexia through Its Immunomodulatory Function
por: Wu, Tsung-Han, et al.
Publicado: (2019)